Ricerca
18 risultati per «costs and cost analysis»
Vaccinazione anti-rotavirus: intervento lodevole ma… fa risparmiare il Sistema Sanitario Nazionale? L’esperienza del Brasile
C. Centenari, G. Maggiore, R.Q. Gurgel, L.E. Cuevas
… J Health Popul Nutr 2008;26:388-96. 11. de Soarez PC, Valentim J, Sartori AM, Novaes HM. Cost-effectiveness analysis of routine rotavirus vaccination in Brazil. Rev Panam Salud Publica 2008;23:221-30. 12. Simoens S. Health Economic Assessment: A Methodological Primer. Int J Environ Res Public …
Vaccinazione anti-rotavirus:intervento lodevole ma… fa risparmiare il sistema sanitario nazionale?L’esperienza del Brasile
C. Centenari, G. Maggiore, R.Q. Gurgel, L.E. Cuevas — pp. 191-192
… dei presunti vaccinabili. Summary The present “budget impact” study assessed the family and health system costs due to diarrhoea in children < 2 years old, before/after the introduction of a rotavirus vaccine in Brazil in 2006. This kind of evaluations plays a crucial role in the assessment of …
Il pediatra e i disturbi gastrointestinali funzionali
G. Primavera, G. Magazzù — pp. 289-295
… B, Sood M, Schwankovsky L, Cocjin J, Zeltzer LK. Visceral painassociated disability syndrome: a descriptive analysis. J Pediatr Gastroenterol Nutr 2002; 35:663-8. 13. Voskuijl WP, Heijmans J, Heijmans HS, Taminiau JA, Benninga MA. Use of Rome II criteria in childhood defecation disorders: …
Position statement sull’uso di farmaci da parte della donna che allatta al seno
Ministero della Salute
… Koren G. Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Int 2012;2012:642893. Zavitsanos AP, MacDonald C, Bassoo E, Gopaul D. Determination of domperidone in human serum and human breast …
Studio di prevalenza della malattia cronica e grave disabilità in età evolutiva e analisi dei costi
M. Grugnetti, P. Cristofanelli, P. Brocani, B. Bruschi, E. Cardinali, S. Cecchi, C. Pellegrini, B. Pimpini, P. Senesi, P. Ragaglia, U. Scuppa, R. Grinta — pp. 243-250
… Bambino 4/2013 PREVALENCE STUDY OF THE CHRONIC DISEASE AND SEVERE DISABILITY IN DEVELOPMENTAL AGE AND COST ANALYSIS (Medico e Bambino 2013;32:243-250) Key words Chronic disease, Severe disabilities, Developmental age, Family paediatricians, Epidemiology, Budget, Training Summary Background - …
La vaccinazione contro il Rotavirus
G. Palla, A. Ventura — pp. 29-33
… di Pisa ROTAVIRUS VACCINE (M&B 1, 29-33, 1997) Key words Rotavirus, Immunization, Diarrhoea, Cost/benefit analysis Summary Rotavirus is the leading cause of severe diarrhoea in infants and causes an estimated 900.000 deaths annually in developing countries. In developed cauntries the rate of …
La profilassi dell’infezione da virus respiratorio sinciziale: dal palivizumab al nirsevimab
Servadio M, Belleudi V, Marchetti F, Addis A. — pp. 632-639
… infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022;399(10340):2047-64. doi: 10.1016/S0140-6736(22)00478-0. 9. Scheltema NM, Gentile A, Lucion F, et al. Global respiratory syncytial virus-associated mortality in young …
Strategie preventive della trasmissione verticale dell'infezione da HIV: la realtà dei paesi con risorse limitate
M. Rabusin, J. Bua
… Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. : J Infect Dis. 2004;189(12):2154-66. 40. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical …
Cosa deve sapere oggi il pediatra del trattamento dell’epatite C nell’era dei nuovi farmaci antivirali?
Veraldi S, Maggiore G. — pp. 303-307
… YA, Calvert C, AbuRaddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014;59(6):765-73. doi: 10. 1093/cid/ciu447. 8. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C |2014-2023 AASLD and IDSA v2023.1 HCV …
Vaccinazione anti-varicella: solo delirio vaccinale?
G. Palla, A. Villirillo, A. Ventura — pp. 381-385
… recommendations have been made by US and italian Health Authorities. Despite a favorable cost-benefit analysis all ready performed in USA, a more general evaluation of the priority of VZV immunization as a public health intervention is needed. Medico e Bambino 6/1997 L a varicella è una …
Visite domiciliari per mamme e bambini: razionale, evidenze, modelli e ipotesi di attuazione
G. Tamburlini — pp. 511-518
… and in the professional. Zero to Three 2010;30(6):44-51. 29. London School of Economics. Cost Benefit Analysis of Interventions with Parents. Research Report DCSF-RW008. UK Department for Children, Schools and Families. 2007. http://www.education.gov.uk/publications/ …
Figli di un dio minore
R. Cavallo — pp. 31-35
… under 2 to be vaccinated against pneumonia. BMJ 2003;327:1249. 5. Melegaro A, Edmunds WJ. Cost effectiveness analysis of PNC conjugate vaccination in England and Wales. Vaccine 2004;22:4203-14. 6. CDC. Preventing pneumococcal disease among infants and young children. MMWR 2000;49:RR-9. 7. Whitney …
Una lista di farmaci condivisa per la pediatria territoriale di famiglia: uno studio osservazionale
D. Piovani, A. Clavenna, M. Bonati e il Gruppo PeFAB — pp. 315-321
… drug use? Clin Pharmacol Ther 2009; 85:581-3. 14. Campi R, Garattini L, Cazzato T, et al. Pharmacoeconomics analysis of prescription in Italian pediatric general practice. Giornale Italiano di Farmacia Clinica 2001;15:30-5. 15. Sturkenboom MC, Verhamme KM, Nicolosi A, et al; TEDDY European …
La tecnologia genetica: ciò che ogni pediatra dovrebbe sapere
Mariani M, Cianci P, Cereda A, Maitz A, Giagnacovo M, Modena P, Iascone M, Selicorni A — pp. 291-301
… doi: 10.1038/gim.2017.264. 5. Srivastava S, Love-Nichols JA, Dies KA, et al. Correction: Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med …
L’immunoterapia specifica orale: sì o no?
G. Longo — pp. 617-620
… biological efficacy but at a more careful scrutiny its widespread use does not appear totally justified. If costs, limited short-term efficacy and no long-term efficacy are taken into account, the traditional iv route still seems preferable. The iv route is more practical, less expensive and, …
Le complicanze della varicella come causa di ospedalizzazione: studio retrospettivo di 27 anni
M.V. Abate, C. Zanchi, E. Barbi, A. Ventura
… cases. Pediatrics 1975;56:512-7. 3. Fornaio P, Gandini F, Marin M, Pedrazzi C. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. Pediatr Infect Dis J 1999;18:414-9. 4. …
Dimensione bambinità: tempo e sogno
P. Costa — pp. 551-553
… JP, Cannon J. Assessing costs and benefits of early childhood Intervention Programs. RAND: Objective Analysis Effective Solutions. https://www.rand.org/pubs/monograph_reports/MR1336.html. Giorgio Tamburlini ACIDO È BELLO Fino a non molto tempo fa un lattante che eccedeva con i rigurgiti e …
La prescrizione di farmaci soggetti a nota nella popolazione pediatrica italiana.
S. Maschi, A. Clavenna, E. Rossi, A. Berti, M. De Rosa, M. Bonati
… (€ 2,3 million, equivalent to 36% of the total expenditure). Conclusions. This study represents the first analysis performed in Italy on the prescription of drugs with AIFA notes in the paediatric population. The main limit of the study is represented by the lack of information about the …